Researching Aptose Biosciences (NASDAQ:APTO) stock? View APTO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at

StockTwits has zero bearing on the price action IMO. The Chardan report is driving this. We've been informed that 2H could be big for the company. Q3 is going to be more of the same (bad like Q1 & 2), Q4 probably ain't gonna be pretty either, and Q1 '17 isn't shaping up too well either at the moment. Find the latest Aptose Biosciences, Inc. (APTO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 12/17/2019 · APTO closed down 8.13 percent on Tuesday, December 17, 2019, on 8.61 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought. Get The Stocktwits Daily Rip. Subscribe. About; Careers; Best Practices; Blog; Developers; Disclaimer

View information about INCO with charts, fundamental and technical data together with current trends, news and users opinions.

In depth view into APTO (Aptose Biosciences) stock including the latest price, news, dividend history, earnings information and financials. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal. Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. 12/31/2019 · Find the latest Aptose Biosciences, Inc. (APTO) stock quote, history, news and other vital information to help you with your stock trading and investing.

12/30/2019 · APTO closed up 0.19 percent on Monday, December 30, 2019, on 73 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while.

Eli Lilly purchased Loxo Oncology for their BTK inhibitor, LOXO-305. Smart money has already came in and more smart money will keep coming depending on what happens with the possibility of the ARQL second bid. Money from ARQL will move into APTO. This is a great short/ mid/ long term investment. Copetrades – StockTwits Aptose Biosciences Researching Aptose Biosciences (NASDAQ:APTO) stock? View APTO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at StockTwits has zero bearing on the price action IMO. The Chardan report is driving this. We've been informed that 2H could be big for the company. Q3 is going to be more of the same (bad like Q1 & 2), Q4 probably ain't gonna be pretty either, and Q1 '17 isn't shaping up too well either at the moment. Find the latest Aptose Biosciences, Inc. (APTO) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors. 12/17/2019 · APTO closed down 8.13 percent on Tuesday, December 17, 2019, on 8.61 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought. Get The Stocktwits Daily Rip. Subscribe. About; Careers; Best Practices; Blog; Developers; Disclaimer 5 Wall Street analysts have issued ratings and price targets for Aptose Biosciences in the last 12 months. Their average twelve-month price target is $6.00, suggesting that the stock has a possible upside of 12.15%. The high price target for APTO is $6.00 and the low price target for APTO is $6.00.

Automakers sold 1.46 million new cars and trucks in October – the best monthly performance since 2001. Demand for trucks and SUVs continues to drive sales ahead of holiday

The latest messages and market ideas from @apto on Stocktwits. The largest community for investors and traders Real-time trade and investing ideas on Alpha Pro Tech Ltd. APT from the largest community of traders and investors.

ST Invest is a wholly owned subsidiary of StockTwits, Inc. Investing in securities products involves risk, including possible loss of principal.

21 Dec 2019 $IBB $AGN $AMGN $APRE $APTO 22 sec ago: The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third  10 Dec 2019 YOURgurlLIKESmyD12/10/19, 07:41 PM · $AKS how's everyone feel about these tomorrow $AKS $WLL $APTO $PTGX $TCCO✅ 🤞 . 2. $BBBY $APTO $CBAY $I $IMGN Made it to my custom gainers list: stocktwits.com/Super1NYC/me 10. 2. Super1NYC12/18/19, 01:27 PM. Top % Gainers: 

Here's a look at the top tickers trending on StockTwits.com Twitter: First ever quarterly report disappoints investors Last night, Twitter (NYSE: TWTR) reported its first ever quarterly report. Automakers sold 1.46 million new cars and trucks in October – the best monthly performance since 2001. Demand for trucks and SUVs continues to drive sales ahead of holiday Compound Trading Chat Room Stock Trading Plan and Watch List Wednesday Mar 7, 2018: OIL #EIA, Trading Boot Camp $LTBR, $ANF, $MOMO, $APTO, $BA, $NFLX, $AOBC, $KO – SP500, $SPY, $SPXL, $SPXS, $BTC, Bitcoin, Gold, $GLD, $GC_F, Gold Miners… Current Technical Analysis and interactive chart for $PLX stock / shares. See the current trading strategy, trend(s), rating and buy and sell signals. After a lot of work I've finally begun creating News for financial advisers, retirement planners and investors on wealth management, retirement planning and personal finance from MarketWatch.